The INCB's participation at CND showed how far the Board has come in terms of supporting human rights norms in the pursuit of drug control obligations, but the Board's outdated inflexibility on cannabis is regrettable.

The hearing will be on the topic of "Young People and Drugs" and will take place on May 8 2019, 10 a.m. to 12.30 p.m. in Vienna, Austria.

The INCB covers developments in the implementation of drug control, including related to cannabis.

To remain relevant, INCB would do well to support governments to negotiate this new terrain rather than seeking to stall and undermine developments in cannabis legislation.

The response by the Board's President to a Thai party including the legal regulation of cannabis in their electoral platform is beyond disproportionate.

The Board has moved some distance from its previous reticence to condemn the use of the death penalty for drug offences.

The INCB’s intervention was an overwhelmingly positive one, promoting better access to controlled medicines, as well as an end to the application of the death penalty and extrajudicial killings in the name of drug control.

The INCB's intransigent position on cannabis is a mixed opportunity to foster dialogue about the increasing reality of legal regulation.

The INCB Watch is running a short series of posts to explore how the Board has changed – or remained the same – over the past decade or so. This post gives an overview of the areas we will analyse in the course of this project.

IDPC analyses the latest alerts published by the INCB on human rights & drug policy, long term opioid usage, tramadol, and the internet drug trade.